文献速递结核与非结核分枝杆菌艾滋病与性传播感染

浓度依赖性拮抗与肺结核培养转阴

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2017-01-01

发现异烟肼Cmax与利福平Cmax/MIC存在负交互作用,异烟肼Cmax<4.6 mg/L且利福平Cmax/MIC<28时异烟肼呈拮抗效应。

要点

  • 异烟肼Cmax<4.6 mg/L且利福平Cmax/MIC<28时,异烟肼对培养转阴有拮抗作用。
  • 异烟肼Cmax>4.6 mg/L时,较高异烟肼暴露与培养转阴率改善相关。
  • 多因素logistic回归校正MIC后未发现PK暴露与2个月培养转阴的关系。

核心结论

  • MARS分析识别出异烟肼Cmax和利福平Cmax/MIC阈值,低于阈值时存在浓度依赖性拮抗,降低2个月痰培养转阴率。

主要发现

  • 多因素logistic回归校正MIC后,PK暴露与2个月培养转阴无关系。
  • MARS识别出异烟肼Cmax与利福平Cmax/MIC对2个月培养转阴的负交互作用。
  • 异烟肼Cmax<4.6 mg/L且利福平Cmax/MIC<28时,异烟肼浓度对培养转阴有拮抗效应。
  • 异烟肼Cmax>4.6 mg/L时,较高异烟肼暴露与培养转阴率改善相关。

关键数值与推荐

  • 异烟肼Cmax阈值4.6 mg/L,利福平Cmax/MIC阈值28,低于阈值时异烟肼呈拮抗效应。

临床怎么用

  • 对肺结核患者应关注异烟肼和利福平的暴露水平,避免异烟肼Cmax<4.6 mg/L且利福平Cmax/MIC<28的联合暴露状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is scant evidence to support target drug exposures for optimal tuberculosis outcomes. We therefore assessed whether pharmacokinetic/pharmacodynamic (PK/PD) parameters could predict 2-month culture conversion. METHODS: One hundred patients with pulmonary tuberculosis (65% human immunodeficiency virus coinfected) were intensively sampled to determine rifampicin, isoniazid, and pyrazinamide plasma concentrations after 7-8 weeks of therapy, and PK parameters determined using nonlinear mixed-effects models. Detailed clinical data and sputum for culture were collected at baseline, 2 months, and 5-6 months. Minimum inhibitory concentrations (MICs) were determined on baseline isolates. Multivariate logistic regression and the assumption-free multivariate adaptive regression splines (MARS) were used to identify clinical and PK/PD predictors of 2-month culture conversion. Potential PK/PD predictors included 0- to 24-hour area under the curve (AUC0-24), maximum concentration (Cmax), AUC0-24/MIC, Cmax/MIC, and percentage of time that concentrations persisted above the MIC (%TMIC). RESULTS: Twenty-six percent of patients had Cmax of rifampicin <8 mg/L, pyrazinamide <35 mg/L, and isoniazid <3 mg/L. No relationship was found between PK exposures and 2-month culture conversion using multivariate logistic regression after adjusting for MIC. However, MARS identified negative interactions between isoniazid Cmax and rifampicin Cmax/MIC ratio on 2-month culture conversion. If isoniazid Cmax was <4.6 mg/L and rifampicin Cmax/MIC <28, the isoniazid concentration had an antagonistic effect on culture conversion. For patients with isoniazid Cmax >4.6 mg/L, higher isoniazid exposures were associated with improved rates of culture conversion. CONCLUSIONS: PK/PD analyses using MARS identified isoniazid Cmax and rifampicin Cmax/MIC thresholds below which there is concentration-dependent antagonism that reduces 2-month sputum culture conversion.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rockwood N, Pasipanodya JG, Denti P, et al. Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis. Clin Infect Dis. 2017. PMID: 28205671. doi:10.1093/cid/cix158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。